Navigating Evidence-Based Interventions for ADHD and ODD.pptx

NAVIGATING EVIDENCE-BASED INTERVENTIONS FOR ADHD AND ODD.

1. Navigating Evidence-Based Interventions for ADHD and ODD"

2. Introduction ADHD and ODD: Key neurodevelopmental disorders discussed. Accurate diagnosis crucial for effective treatment plans (Fernandes et al., 2020). Presentation aims to enhance understanding and awareness. Recognize importance of addressing behavioral challenges. Highlight significance of distinguishing between ADHD, ODD. Focus on guiding towards tailored interventions. Clarify objectives: inform, educate, promote collaboration.

3. ADHD Definition and DSM-5 Criteria ADHD characterized by attention difficulties, hyperactivity. DSM-5 outlines specific criteria for diagnosis. Criteria include symptoms onset before age 12. Persistent symptoms affecting daily functioning required. Three subtypes: inattentive, hyperactive-impulsive, combined. Diagnosis based on presence of specific symptoms. Understanding criteria essential for accurate diagnosis.

4. ODD Definition and DSM-5 Criteria ODD marked by defiance, hostility, and vindictiveness. DSM-5 outlines specific criteria for diagnosis. Criteria include frequent and persistent pattern. Differentiated from conduct disorder by severity. Conduct disorder involves more severe violations. Understanding criteria aids in accurate diagnosis.

5. Assessment Tools Assessment crucial for accurate diagnosis and intervention. Various tools available to assess behavioral patterns. Vanderbilt Assessment Scales gather data from multiple sources. ADHD Rating Scale-IV evaluates ADHD symptoms. Connors Comprehensive Behavior Rating Scales assess behavior (Marshall et al., 2021). Child Behavior Checklist identifies various behavioral issues. Eyberg Child Behavior Inventory and Achenbach System of Empirically Based Assessment useful too.

6. Medication Interventions for ADHD and ODD Psychopharmacological management crucial in treating ADHD, ODD. Stimulant drugs like methylphenidate, amphetamines often prescribed. Non-stimulant drugs such as guanfacine, atomoxetine utilized. Ethical considerations include overdiagnosis, proper monitoring. Monitoring guidelines essential for ensuring medication effectiveness. Understanding medication options aids in treatment planning.

7. Non-Medication Therapeutic Approaches: Cognitive Behavioral Therapy (CBT) CBT principles focus on thoughts, behaviors' interaction. CBT applied to address ADHD, ODD symptoms. Evidence supports CBT's effectiveness in improving behaviors. Cognitive restructuring helps challenge and modify thoughts. Behavior modification techniques target specific problematic behaviors. CBT empowers individuals to develop coping strategies.

8. Non-Medication Therapeutic Approaches: PCIT PCIT focuses on interactions. PCIT aims to improve parent-child relationships. Goals include enhancing communication, discipline techniques. PCIT addresses behavioral issues through structured interactions. Research evidences PCIT's effectiveness in improving behaviors. Techniques include praise, positive reinforcement, consistent discipline.

9. Evidence-Based Interventions Summary of evidence-based interventions for ADHD, ODD. Articles by Rodrigues et al., (2020) and Fu et al., (2022). Medication modalities include methylphenidate and atomoxetine. Therapy approaches support comprehensive treatment strategies. Research evidence guides treatment decisions and interventions. References provide valuable insights into treatment options.

10. Interdisciplinary Team Collaboration Collaboration enhances treatment outcomes for ADHD, ODD. Involves healthcare professionals, educators, and parents. Each member contributes unique expertise and perspectives. Interdisciplinary approach ensures holistic care provision. Educators provide insights into academic performance, behavior. Parents offer valuable information about home environment.

11. Interdisciplinary Team Collaboration Contd. Improved treatment outcomes through comprehensive care provision ( Birkell et al., 2021). Enhanced understanding of the child's needs and challenges. Increased effectiveness of interventions through combined expertise. Better coordination of care across multiple settings. Support for families in navigating complex treatment options. Opportunity for ongoing learning and professional development.

12. Conclusion Recap: ADHD, ODD complexities and treatment approaches. Personalized treatments crucial for effective management. Ongoing research enhances understanding and interventions. Collaboration among stakeholders improves patient outcomes. Encourage continuous collaboration and research efforts. Thank you for your attention and participation. Let's continue working together for better outcomes.

13. References Brikell , I., Wimberley, T., Albiñana , C., Pedersen, E. M., Vilhjálmsson , B. J., Agerbo , E., ... & Dalsgaard, S. (2021). Genetic, clinical, and sociodemographic factors associated with stimulant treatment outcomes in ADHD. American Journal of Psychiatry, 178(9), 854-864. https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2020.20121686 Fernandes, S. L., Tanik , U. J., Rajinikanth, V., & Karthik, K. A. (2020). A reliable framework for accurate brain image examination and treatment planning based on early diagnosis support for clinicians. Neural Computing and Applications, 32, 15897-15908. https://link.springer.com/article/10.1007/s00521-019-04369-5 Fu, D., Wu, D. D., Guo, H. L., Hu, Y. H., Xia, Y., Ji, X., ... & Liu, Q. Q. (2022). The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for ADHD therapy in children: a narrative review. Frontiers in Psychiatry, 12, 780921. https://www.frontiersin.org/articles/10.3389/fpsyt.2021.780921/full

14. Marshall, P., Hoelzle , J., & Nikolas, M. (2021). Diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD) in young adults: A qualitative review of the utility of assessment measures and recommendations for improving the diagnostic process. The Clinical Neuropsychologist, 35(1), 165-198. https://www.tandfonline.com/doi/abs/10.1080/13854046.2019.1696409 Rodrigues, R., Lai, M. C., Beswick, A., Gorman, D. A., Anagnostou , E., Szatmari , P., ... & Ameis , S. H. (2021). Practitioner review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: A systematic review and meta‐analysis. Journal of Child Psychology and Psychiatry, 62(6), 680-700. https://acamh.onlinelibrary.wiley.com/doi/abs/10.1111/jcpp.13305?casa_token=pWbfPNNSj1MAAAAA:eubMMIUUZHymDhBHcn-4Ptkw_cf3K0nvuxOR23qKV2CcWVJQKwE0fk8565x7P56csqpX7tirel38exO8